🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
Combination treatment with antiangiogenic agents and anti-programmed cell d...
Status
Unknown
Location
Zhongshan Hospital, Fudan University
Start Date
2020-12-23
Trial ID
NCT04639284
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of hepatic...
Status
Active Not Recruiting
Location
The first hospital of China medical university
Start Date
2024-08-16
Trial ID
NCT06632106
This is an open label, multi-center, single arm study to evaluate the effic...
Status
Unknown
Location
Anhui province hospital
Start Date
2022-07-25
Trial ID
NCT05407519
Treatments Being Tested
This was an open label, multicenter, Phase 2 study designed to assess the e...
Status
Completed
Location
Fujian Cancer Hospital
Start Date
2021-04-19
Trial ID
NCT04716634
Treatments Being Tested
Background: Ablation is important radical treatment in hepatocellular carci...
Status
Unknown
Location
302 Hospital
Start Date
2021-12-22
Trial ID
NCT06059885
Treatments Being Tested
This trial is designed to explore the efficacy and safety of interventional...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2025-02-19
Trial ID
NCT07157969
This is a randomized, controlled, open-label, multicenter clinical study to...
Status
Terminated
Location
Maanshan People's Hospital
Start Date
2025-04-07
Trial ID
NCT06897579
The aim of this study is to the efficacy, prognosis, adverse effects, and f...
Status
Unknown
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2022-01-20
Trial ID
NCT05717738
The purpose of this study is to assess the efficacy and safety of sitravati...
Status
Unknown
Location
Fudan University Shanghai Cancer
Start Date
2021-04-01
Trial ID
NCT04734262
Treatments Being Tested